Recursion announced plans to open a new office in London’s King’s Cross neighborhood. Set to formally open in June, the site will provide Recursion and Valence Labs, the company’s artificial intelligence research engine, access to world-class talent across Europe’s rapidly growing TechBio sector and embed Recursion in a thriving innovation ecosystem of leading technology and life science companies. Recursion’s 6,700 square foot London office will be located at 3 Pancras Square, King’s Cross London. The building is part of a 67-acre redevelopment project in King’s Cross, with over 4.5M square feet of office space.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on RXRX:
- Recursion Announces Plans to Open New Office in London
- Recursion Pharmaceuticals call volume above normal and directionally bullish
- Recursion Hosts Second Annual Rare Disease Day Events for Utah’s Rare Disease Community
- Recursion to Participate in Upcoming Investor Conferences
- Recursion Pharmaceuticals reports Q4 EPS (42c), consensus (45c)